Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1990 Sep;30(3):353–364. doi: 10.1111/j.1365-2125.1990.tb03784.x

The measurement of quality of life in hypertensive patients: a practical approach.

C J Bulpitt 1, A E Fletcher 1
PMCID: PMC1368136  PMID: 2223414

Full text

PDF
364

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergner M., Bobbitt R. A., Carter W. B., Gilson B. S. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981 Aug;19(8):787–805. doi: 10.1097/00005650-198108000-00001. [DOI] [PubMed] [Google Scholar]
  2. Bulpitt C. J., Dollery C. T., Carne S. A symptom questionnaire for hypertensive patients. J Chronic Dis. 1974 Aug;27(6):309–323. doi: 10.1016/0021-9681(74)90094-0. [DOI] [PubMed] [Google Scholar]
  3. Bulpitt C. J., Dollery C. T., Carne S. Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J. 1976 Feb;38(2):121–128. doi: 10.1136/hrt.38.2.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fava G. A., Kellner R., Munari F., Pavan L. The Hamilton Depression Rating Scale in normals and depressives. Acta Psychiatr Scand. 1982 Jul;66(1):26–32. doi: 10.1111/j.1600-0447.1982.tb00911.x. [DOI] [PubMed] [Google Scholar]
  5. Fletcher A. E., Bulpitt C. J., Hawkins C. M., Havinga T. K., ten Berge B. S., May J. F., Schuurman F. H., van der Veur E., Wesseling H. Quality of life on antihypertensive therapy: a randomized double-blind controlled trial of captopril and atenolol. J Hypertens. 1990 May;8(5):463–466. doi: 10.1097/00004872-199005000-00011. [DOI] [PubMed] [Google Scholar]
  6. Fletcher A. E., Chester P. C., Hawkins C. M., Latham A. N., Pike L. A., Bulpitt C. J. The effects of verapamil and propranolol on quality of life in hypertension. J Hum Hypertens. 1989 Apr;3(2):125–130. [PubMed] [Google Scholar]
  7. Fletcher A. E., Hunt B. M., Bulpitt C. J. Evaluation of quality of life in clinical trials of cardiovascular disease. J Chronic Dis. 1987;40(6):557–569. doi: 10.1016/0021-9681(87)90014-2. [DOI] [PubMed] [Google Scholar]
  8. Kellner R., Rada R. T., Andersen T., Pathak D. The effects of chlordiazepoxide on self-rated depression, anxiety, and well-being. Psychopharmacology (Berl) 1979 Aug 8;64(2):185–191. doi: 10.1007/BF00496060. [DOI] [PubMed] [Google Scholar]
  9. Kellner R., Sheffield B. F. A self-rating scale of distress. Psychol Med. 1973 Feb;3(1):88–100. doi: 10.1017/s0033291700046377. [DOI] [PubMed] [Google Scholar]
  10. Robin A., Curry S. H., Whelpton R. Clinical and biochemical comparison of clorazepate and diazepam. Psychol Med. 1974 Nov;4(4):388–392. doi: 10.1017/s0033291700045839. [DOI] [PubMed] [Google Scholar]
  11. Rosser R., Kind P. A scale of valuations of states of illness: is there a social consensus? Int J Epidemiol. 1978 Dec;7(4):347–358. doi: 10.1093/ije/7.4.347. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES